Identification of a serum proteomic biomarker panel using diagnosis specific ensemble learning and symptoms for early pancreatic cancer detection
Alexander Ney, Nuno R. Nené, Eva Sedlak, Pilar Acedo, Oleg Blyuss, Harry J. Whitwell, Eithne Costello, Aleksandra Gentry-Maharaj, Norman R. Williams, Usha Menon, Giuseppe K. Fusai, Alexey Zaikin, Stephen P. Pereira
doi: https://doi.org/10.1101/2023.12.24.23300505
Alexander Ney
1rd, Rowland Hill Street, London NW3 2PF, United Kingdom
Nuno R. Nené
2Department of Women’s Cancer, EGA Institute for Women’s Health, University College London, 84-86 Chenies Mews, London, WC1E 6HU, United Kingdom
3Cancer Institute, University College London, 72 Huntley St, London, WC1E 6DD, United Kingdom
4Department of Statistical Science, University College London 1-19 Torrington Place, London, WC1E 6BT, United Kingdom
Eva Sedlak
2Department of Women’s Cancer, EGA Institute for Women’s Health, University College London, 84-86 Chenies Mews, London, WC1E 6HU, United Kingdom
Pilar Acedo
1rd, Rowland Hill Street, London NW3 2PF, United Kingdom
Oleg Blyuss
2Department of Women’s Cancer, EGA Institute for Women’s Health, University College London, 84-86 Chenies Mews, London, WC1E 6HU, United Kingdom
5Wolfson Institute of Population Health, Queen Mary University of London, Charterhouse Square, EC1M 6BQ, London, United Kingdom
6Department of Pediatrics and Pediatric Infectious Diseases, Institute of Child’s Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
Harry J. Whitwell
2Department of Women’s Cancer, EGA Institute for Women’s Health, University College London, 84-86 Chenies Mews, London, WC1E 6HU, United Kingdom
7National Phenome Centre and Imperial Clinical Phenotyping Centre, Department of Metabolism, Digestion and Reproduction, IRDB, Building Imperial College London, W12 ONN, United Kingdom
8Section of Bioanalytical Chemistry, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Sir Alexander Fleming Building, Imperial College London, SW7 2AZ, United Kingdom
Eithne Costello
9Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom
Aleksandra Gentry-Maharaj
2Department of Women’s Cancer, EGA Institute for Women’s Health, University College London, 84-86 Chenies Mews, London, WC1E 6HU, United Kingdom
10MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, 90 High Holborn, 2nd Floor, London, WC1V 6LJ, United Kingdom
Norman R. Williams
11Division of Surgery & Interventional Science, University College London, London, United Kingdom
Usha Menon
10MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, 90 High Holborn, 2nd Floor, London, WC1V 6LJ, United Kingdom
Giuseppe K. Fusai
12HPB & Liver Transplant Unit, Royal Free London, London NW3 2QG, United Kingdom
Alexey Zaikin
2Department of Women’s Cancer, EGA Institute for Women’s Health, University College London, 84-86 Chenies Mews, London, WC1E 6HU, United Kingdom
13Institute for Cognitive Neuroscience, University Higher School of Economics, Moscow, Russia
14Department of Mathematics, University College London, London WC1H 0AY, United Kingdom
Stephen P. Pereira
1rd, Rowland Hill Street, London NW3 2PF, United Kingdom
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
Data requestors will need to sign a data access agreement and in keeping with patient consent for secondary use obtain ethical approval for any new analyses.
Posted December 28, 2023.
Identification of a serum proteomic biomarker panel using diagnosis specific ensemble learning and symptoms for early pancreatic cancer detection
Alexander Ney, Nuno R. Nené, Eva Sedlak, Pilar Acedo, Oleg Blyuss, Harry J. Whitwell, Eithne Costello, Aleksandra Gentry-Maharaj, Norman R. Williams, Usha Menon, Giuseppe K. Fusai, Alexey Zaikin, Stephen P. Pereira
medRxiv 2023.12.24.23300505; doi: https://doi.org/10.1101/2023.12.24.23300505
Identification of a serum proteomic biomarker panel using diagnosis specific ensemble learning and symptoms for early pancreatic cancer detection
Alexander Ney, Nuno R. Nené, Eva Sedlak, Pilar Acedo, Oleg Blyuss, Harry J. Whitwell, Eithne Costello, Aleksandra Gentry-Maharaj, Norman R. Williams, Usha Menon, Giuseppe K. Fusai, Alexey Zaikin, Stephen P. Pereira
medRxiv 2023.12.24.23300505; doi: https://doi.org/10.1101/2023.12.24.23300505
Subject Area
Subject Areas
- Addiction Medicine (347)
- Allergy and Immunology (666)
- Anesthesia (181)
- Cardiovascular Medicine (2637)
- Dermatology (223)
- Emergency Medicine (398)
- Epidemiology (12211)
- Forensic Medicine (10)
- Gastroenterology (758)
- Genetic and Genomic Medicine (4087)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2646)
- Health Policy (1003)
- Hematology (362)
- HIV/AIDS (850)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (433)
- Neurology (3862)
- Nursing (209)
- Nutrition (577)
- Oncology (2022)
- Ophthalmology (584)
- Orthopedics (240)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (472)
- Pediatrics (1113)
- Primary Care Research (450)
- Public and Global Health (6516)
- Radiology and Imaging (1398)
- Respiratory Medicine (871)
- Rheumatology (404)
- Sports Medicine (342)
- Surgery (444)
- Toxicology (52)
- Transplantation (185)
- Urology (165)